Ancora Accucinch -Ventricular Restoration System for Patients
Heart failure, sometimes called congestive heart failure or CHF, is a condition in which your heart slowly weakens and loses its ability to pump enough oxygen-rich blood to the body. It is a chronic, progressive disease, which means there is no cure.
About half of heart failure patients have a reduced ejection fraction and an enlarged left ventricle (the main pumping chamber of the heart). This causes more stress on the heart and leads to reduced pumping efficiency and heart failure symptoms.
The AccuCinch Ventricular Restoration System has been granted Breakthrough Device Designation by the FDA, a program designation for certain medical devices that may provide for more effective treatment options for patients with life-threatening or irreversibly debilitating diseases or conditions. Learn more about the FDA Breakthrough Devices Program here.
CAUTION – Investigational device. Limited by United States law to investigational use.
During a minimally invasive, catheter-based procedure, a flexible implant is attached to the inner wall of your heart’s left ventricle and then cinched. The implant is intended to reduce the size of your left ventricle and support and strengthen the wall of your heart.
As a complement to existing care, the AccuCinch System is a new approach to heart failure therapy that may help reduce symptoms, improve quality of life and potentially increase life expectancy.
TREATMENT OPTIONS
After a diagnosis of heart failure, your physician may prescribe medications to help treat symptoms and provide guidance on important lifestyle modifications, such as making changes to your diet and increasing the amount of exercise you do. In some cases, you may also be prescribed an implantable pacemaker, or cardiac resynchronization therapy device, to help manage symptoms and improve heart function.
However, when your condition eventually progresses beyond the ability of medications or pacemakers to manage symptoms, often the only options left include implantation of a left ventricular assist device (LVAD) or a heart transplant.
